Reuters logo
BRIEF-Ligand Pharmaceuticals Q4 adjusted earnings per share $0.74
February 23, 2017 / 9:24 PM / 9 months ago

BRIEF-Ligand Pharmaceuticals Q4 adjusted earnings per share $0.74

Feb 23 (Reuters) - Ligand Pharmaceuticals Inc

* Ligand reports fourth quarter and full year 2016 financial results

* Q4 adjusted earnings per share $0.74

* Q4 GAAP loss per share $0.15

* Q4 revenue $38.2 million versus I/B/E/S view $40.3 million

* Q4 earnings per share view $1.19 -- Thomson Reuters I/B/E/S

* Ligand Pharmaceuticals says estimates 2017 core revenue to include royalties of about $87 million, material sales of about $23 million, contract payments of at least $20 million

* Ligand Pharmaceuticals Inc says estimates that cash expenses for 2017 will be in range of $28 million to $30 million Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below